The Korean Version of Skindex-29

Korean Journal of Dermatology

Volumn 42, Issue 1, 2004, Pages 9-15

  Ahn, Bong Kyun ^a   Lee, Sang Ju ^a   Namkoong, Ki ^a   Chung, Yae Lee ^a   Lee, Seung Hun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cross cultural Adaptation; Dermatologic Quality of Life; Reliability; Skindex 29; Validity

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DERMATOLOGY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OUTPATIENT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SKIN DEFECT; SKIN DISEASE; SKIN INFLAMMATION; SPAIN; UNITED STATES; VALIDATION PROCESS;

EID: 1842787436     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jones-Caballero M, Penas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of Skindex-29. Cultural adaptation and preliminary evidence of validity and equivalence with the original American version. Int J Dermatol 2000;39:907-912
2. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: An Italian study on 2,242 dermatological outpatients. Dermatology 2002;204:43-49
3. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001;144:1038-1043
4. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality of life impairment in neurofibromatosis type 1. Arch Dermatol 2001;137:1421-1430
5. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432
6. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:291-296
7. Mckenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996;34:534-538
8. Finlay AY. The outcomes movement and new measures of psoriasis. J Am Acad Dermatol 1997;36:502-503
9. Jemec GB, Wulf HC. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 1996;21:177-179
10. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707-713
11. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-1440
12. Hunt SM, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S. Cross-cultural adaptation of health measures. European Group for Health Management and Quality of Life Assessment. Health Policy. 1991;19:33-44
13. Shuster S, Fisher G, Harris E, Binnell D. The effects of skin disease on self-image. Br J Dermatol 1978;99: 18-19
14. Jowett S & Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-429
15. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32
16. Wu SF, Kinder BN, Trannell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18:325-333
17. Lucas CJ. Personality of students with acne vulgaris. BMJ 1961;2:354
18. Wittkower E. Acne vulgaris: a psychosomatic study. Br J Dermatol 1951;63:214-223
19. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991;8:332-338
20. Myhill JE, Leichtman SR, Burnett JW. Self-esteem and social assertiveness in patients receiving isotretinoin treatment for cystic acne. Cutis 1988;41:171-173
21. Schachter RJ, Pantel ES, Glassman GM, Zweibelson I. Acne vulgaris and psychologic impact on high school students. N Y State J Med 1971;71:2886-2890
22. Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM. The psychological impact of severe acne. Cutis. 1985;36:84-86